Location History:
- Seeheim, DE (1978 - 1980)
- Seeheim-Jugenheim, DE (1981)
- Pfungstadt, DE (1985 - 1989)
Company Filing History:
Years Active: 1978-1989
Title: Helmut Strecker: A Pioneer in Thyronine Derivatives and Immunological Determination
Introduction
Helmut Strecker is a prominent inventor based in Seeheim, Germany, known for his contributions to the field of biochemistry and pharmaceuticals. With a remarkable portfolio of five patents to his name, Strecker has made significant strides in the development of innovative compounds and methods used in medical diagnostics.
Latest Patents
Strecker's latest patented inventions include novel thyronine derivatives, characterized by a specific chemical formula where 'n' ranges from 1 to 6, and R can denote hydroxyl, alkyl, or aryl groups. His work on these derivatives involves a process for their preparation and their application in conducting radioimmunoassays. Additionally, he has developed a procedure for the immunologic determination of procollagen peptides, further advancing the field of immunology by enabling the simultaneous determination of procollagen peptide (type III) and procollagen peptide col 1 (type III) in a single assay.
Career Highlights
Helmut Strecker's career is highlighted by his association with Hoechst Aktiengesellschaft, a leading pharmaceutical company where he has conducted much of his research and development. His patents reflect a commitment to enhancing medical diagnostics through innovative technologies.
Collaborations
Throughout his career, Strecker has collaborated with esteemed colleagues such as Gerhard Kloss and Rupert Timpl. These collaborations have fostered an environment of shared knowledge and expertise, leading to advancements in their respective fields and contributing to the success of their joint projects.
Conclusion
Helmut Strecker stands out as a dedicated inventor whose work has had a lasting impact on the realms of biochemistry and medical diagnostics. His innovative patents and collaborations underscore his influential role in advancing healthcare technologies, ensuring that his contributions will benefit the scientific community for years to come.